Abrogation of neuroinflammation and behavioural deficit by Chlorogenic acid and Tinosporia cordiofolia in MPTP-Induced Parkinsonian mice model via suppressing NF-κB pathway
Objective: The current study was designed with the aim to investigate the anti-neuroinflammatory activity of chlorogenic acid (CGA) and ethanolic extract of Tinospora cordifolia (TPE)…Stimulation parameters of subthalamic deep brain stimulation in dystonia: a systematic review
Objective: To systematically analyze the stimulation parameters of the subthalamic nucleus (STN) deep brain stimulation (DBS) in patients with dystonia. Background: DBS is widely used…A New Complex dystonic presentation of a rare gene – CACNA1B and its response to Levodopa
Objective: We report a case of complex dystonia with the rare gene- CACNA1B. Background: CACNA1B gene has previously been reported as the cause of myoclonus-…Neural bases of dystonia penetrance and manifestation
Objective: To identify functional and structural brain organization relevant to disease penetrance and clinical manifestation in patients with familial laryngeal dystonia (LD) and their unaffected…Clinical and etiological aspects of movement disorders in a low-income country: Case of Mali
Objective: Describing Clinical and etiological aspects of movement disorders in Mali Background: Movement disorders (MD) correspond to a disturbance in the programming and / or…The incidence, predictors, and outcomes of delirium in Parkinson’s disease and atypical parkinsonism
Objective: To explore (i) the incidence of, (ii) the risk factors for, and (iii) the outcomes after, the first hospital episode of delirium in both…Measuring Unmet Need in Underserved Parkinson’s Populations (UPPs)
Objective: To identify health care needs and barriers among people with Parkinson's disease who are underserved so as to inform strategies to better serve this…Movement disorders associated with expansions and intermediate repeats in the C9orf72 gene
Objective: This work sought to investigate the frequency and characteristics of movement disorders (MD) associated with repeat expansions or intermediate repeats in the C9orf72 gene.…Genetic analysis of Huntington’s Disease in a Brazilian Amazonian population
Objective: Characterize genetically a series of cases of patients with Huntington’s disease and their family members at risk in the city of Manaus, capital of…Cytokines and Brain Specific Antibodies in Experimental Cellular and Molecular Treatment of Huntington’s Diseases
Objective: Huntington’s Disease (HD) is a severe neurodegenerative disorder main pathogenic factor is CAG repeats in a suffered patients genome. Experimental therapy on the model…
- « Previous Page
- 1
- …
- 122
- 123
- 124
- 125
- 126
- …
- 149
- Next Page »